Radiation zaps resistant lung cancer spots, may extend time on current drugs
NCT ID NCT06813664
First seen Feb 28, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study tests whether giving precise, high-dose radiation to a few growing cancer spots can help patients with metastatic non-small cell lung cancer stay on their current targeted therapy longer. About 60 adults whose cancer has started to progress on a targeted drug will receive radiation to those spots. The goal is to see if this approach delays the need to switch to a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.